Read Our Blog

Call Us: (913) 544-1199

A Class Issue: Biopharmaceutics Classification System and Pediatrics

Amanda Stevenson-Grund - Friday, December 30, 2016

The applicability of the biopharmaceutics system to paediatric product development has yet to be explored.” – Batchelor, Int J Pharm. 2014; 469: 251

The Biopharmaceutics Classification System has flaws when it comes to pediatrics

In school, we’re taught that cutting class is bad. It certainly has negative consequences on one’s grade point average. However, cutting class as in dropping outdated classification systems can be beneficial. For example, the Biopharmaceutics Classification System (BCS) has flaws when it comes to pediatric drugs.

 More >

The Danger Zone: Extemporaneous Formulations

Amanda Stevenson-Grund - Friday, December 16, 2016

Extemporaneous preparation is one of the highest risk activities carried out in pharmacy today and is often supported by a poor quality evidence base.
Lowey and Jackson, The Pharmaceutical Journal. 2008

Drugs represent the dangers of extemporaneous formulations

Journalists and police officials often report wanted suspects as “armed and dangerous.” The two words often come in a pair, but a situation doesn’t require arms to be dangerous. In the medical field, extemporaneous formulations can be dangerous due to the potential for incorrect dosing and a lack of information.

 More >

More Than Skin-deep: Challenges in Treating Skin and Soft Tissue Infections

Amanda Stevenson-Grund - Friday, December 02, 2016

Skin and soft tissue infections (SSTIs) are ubiquitous and the most common of infections, suffered by everyone at some point to a lesser or greater degree and encountered by all doctors.” – Dryden, J. Antimicrob. Chemother. 2010: 65 (suppl 3): iii35-iii44

A patient with a skin or soft tissue infection is seen by a physician

Skin is the human body’s largest organ. It’s a “fun fact” that many children learn. What many children don’t learn about, however, are skin and soft tissue infections, which can affect both adults and children. Skin and soft tissue infections can become serious if not treated promptly, but some of the medications used to treat such infections, such as clindamycin, can lead to noncompliance, especially in children.

 More >